Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial

Author:

Brun Marthe Kirkesæther12ORCID,Goll Guro Løvik1ORCID,Jørgensen Kristin Kaasen3,Sexton Joseph1,Gehin Johanna Elin24,Sandanger Øystein5,Olsen Inge Christoffer6,Klaasen Rolf Anton4,Warren David John4,Mørk Cato7,Kvien Tore K.12,Jahnsen Jørgen23,Bolstad Nils4,Haavardsholm Espen A.12,Syversen Silje Watterdal1

Affiliation:

1. Division of Rheumatology and Research Diakonhjemmet Hospital Oslo Norway

2. Institute of Clinical Medicine University of Oslo Oslo Norway

3. Department of Gastroenterology Akershus University Hospital Lørenskog Norway

4. Department of Medical Biochemistry Oslo University Hospital Oslo Norway

5. Section of Dermatology Oslo University Hospital Oslo Norway

6. Department of Research Support for Clinical Trials Oslo University Hospital Oslo Norway

7. Akershus Dermatology Center Lørenskog Norway

Publisher

Wiley

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3